DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 99 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $896,000 | +23.1% | 44,429 | +127.6% | 0.00% | +33.3% |
Q2 2021 | $728,000 | +35.3% | 19,519 | -7.3% | 0.00% | 0.0% |
Q1 2021 | $538,000 | -23.7% | 21,050 | -34.2% | 0.00% | -25.0% |
Q4 2020 | $705,000 | +14.6% | 31,994 | -6.4% | 0.00% | 0.0% |
Q3 2020 | $615,000 | -2.8% | 34,184 | +37.1% | 0.00% | -20.0% |
Q2 2020 | $633,000 | +115.3% | 24,934 | +56.0% | 0.01% | +66.7% |
Q1 2020 | $294,000 | +50.0% | 15,986 | +79.3% | 0.00% | +50.0% |
Q4 2019 | $196,000 | +19.5% | 8,917 | -21.8% | 0.00% | +100.0% |
Q3 2019 | $164,000 | -59.6% | 11,396 | -55.8% | 0.00% | -66.7% |
Q2 2019 | $406,000 | -28.6% | 25,799 | -33.6% | 0.00% | -40.0% |
Q1 2019 | $569,000 | – | 38,825 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |